Literature DB >> 28811072

Evolution of hemoglobin loci and their regulatory elements.

Sjaak Philipsen1, Ross C Hardison2.   

Abstract

Across the expanse of vertebrate evolution, each species produces multiple forms of hemoglobin in erythroid cells at appropriate times and in the proper amounts. The multiple hemoglobins are encoded in two globin gene clusters in almost all species. One globin gene cluster, linked to the gene NPRL3, is preserved in all vertebrates, including a gene cluster encoding the highly divergent globins from jawless vertebrates. This preservation of synteny may reflect the presence of a powerful enhancer of globin gene expression in the NPRL3 gene. Despite substantial divergence in noncoding DNA sequences among mammals, several epigenetic features of the globin gene regulatory regions are preserved across vertebrates. The preserved features include multiple DNase hypersensitive sites, at least one of which is an enhancer, and binding by key lineage-restricted transcription factors such as GATA1 and TAL1, which in turn recruit coactivators such as P300 that catalyze acetylation of histones. The maps of epigenetic features are strongly correlated with activity in gene regulation, and resources for accessing and visualizing such maps are readily available to the community of researchers and students.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Evolution; Globin genes; Locus control regions; Super-enhancers; Transcriptional regulation

Mesh:

Substances:

Year:  2017        PMID: 28811072      PMCID: PMC5807248          DOI: 10.1016/j.bcmd.2017.08.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  112 in total

1.  Stochastic patterns in globin gene expression are established prior to transcriptional activation and are clonally inherited.

Authors:  Mariken de Krom; Mariette van de Corput; Marieke von Lindern; Frank Grosveld; John Strouboulis
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

2.  Looping and interaction between hypersensitive sites in the active beta-globin locus.

Authors:  Bas Tolhuis; Robert Jan Palstra; Erik Splinter; Frank Grosveld; Wouter de Laat
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

3.  DNA loops induced by cooperative binding of lambda repressor.

Authors:  J Griffith; A Hochschild; M Ptashne
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

4.  c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression.

Authors:  Elisa Bianchi; Roberta Zini; Simona Salati; Elena Tenedini; Ruggiero Norfo; Enrico Tagliafico; Rossella Manfredini; Sergio Ferrari
Journal:  Blood       Date:  2010-08-04       Impact factor: 22.113

5.  A dominant chromatin-opening activity in 5' hypersensitive site 3 of the human beta-globin locus control region.

Authors:  J Ellis; K C Tan-Un; A Harper; D Michalovich; N Yannoutsos; S Philipsen; F Grosveld
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

6.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

7.  Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression.

Authors:  Yong Cheng; Weisheng Wu; Swathi Ashok Kumar; Duonan Yu; Wulan Deng; Tamara Tripic; David C King; Kuan-Bei Chen; Ying Zhang; Daniela Drautz; Belinda Giardine; Stephan C Schuster; Webb Miller; Francesca Chiaromonte; Yu Zhang; Gerd A Blobel; Mitchell J Weiss; Ross C Hardison
Journal:  Genome Res       Date:  2009-11-03       Impact factor: 9.043

8.  5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.

Authors:  T J Ley; J DeSimone; C T Noguchi; P H Turner; A N Schechter; P Heller; A W Nienhuis
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

9.  Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.

Authors:  Jian Xu; Daniel E Bauer; Marc A Kerenyi; Thuy D Vo; Serena Hou; Yu-Jung Hsu; Huilan Yao; Jennifer J Trowbridge; Gail Mandel; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

Review 10.  World distribution, population genetics, and health burden of the hemoglobinopathies.

Authors:  Thomas N Williams; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

View more
  8 in total

1.  An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells.

Authors:  Masato Miyata; Nynke Gillemans; Dorit Hockman; Jeroen A A Demmers; Jan-Fang Cheng; Jun Hou; Matti Salminen; Christopher A Fisher; Stephen Taylor; Richard J Gibbons; Jared J Ganis; Leonard I Zon; Frank Grosveld; Eskeatnaf Mulugeta; Tatjana Sauka-Spengler; Douglas R Higgs; Sjaak Philipsen
Journal:  Blood       Date:  2020-07-16       Impact factor: 22.113

2.  S3norm: simultaneous normalization of sequencing depth and signal-to-noise ratio in epigenomic data.

Authors:  Guanjue Xiang; Cheryl A Keller; Belinda Giardine; Lin An; Qunhua Li; Yu Zhang; Ross C Hardison
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

3.  Identification of the transcription factor MAZ as a regulator of erythropoiesis.

Authors:  Darya Deen; Falk Butter; Deborah E Daniels; Ivan Ferrer-Vicens; Daniel C J Ferguson; Michelle L Holland; Vasiliki Samara; Jacqueline A Sloane-Stanley; Helena Ayyub; Matthias Mann; Jan Frayne; David Garrick; Douglas Vernimmen
Journal:  Blood Adv       Date:  2021-08-10

4.  Epigenetic activities in erythroid cell gene regulation.

Authors:  Yu Wang; Lei Yu; James Douglas Engel; Sharon A Singh
Journal:  Semin Hematol       Date:  2020-12-15       Impact factor: 3.851

Review 5.  Physiological and Aberrant γ-Globin Transcription During Development.

Authors:  Gloria Barbarani; Agata Labedz; Sarah Stucchi; Alessia Abbiati; Antonella E Ronchi
Journal:  Front Cell Dev Biol       Date:  2021-04-01

6.  Reactivation of a developmentally silenced embryonic globin gene.

Authors:  Andrew J King; Duantida Songdej; Damien J Downes; Robert A Beagrie; Siyu Liu; Megan Buckley; Peng Hua; Maria C Suciu; A Marieke Oudelaar; Lars L P Hanssen; Danuta Jeziorska; Nigel Roberts; Stephanie J Carpenter; Helena Francis; Jelena Telenius; Aude-Anais Olijnik; Jacqueline A Sharpe; Jacqueline Sloane-Stanley; Jennifer Eglinton; Mira T Kassouf; Stuart H Orkin; Len A Pennacchio; James O J Davies; Jim R Hughes; Douglas R Higgs; Christian Babbs
Journal:  Nat Commun       Date:  2021-07-21       Impact factor: 14.919

7.  Identification of a Novel Enhancer/Chromatin Opening Element Associated with High-Level γ-Globin Gene Expression.

Authors:  Yong Shen; MacLean A Bassett; Aishwarya Gurumurthy; Rukiye Nar; Isaac J Knudson; Cameron R Guy; Alex Perez; Russell W Mellen; Masatoshi Ikeda; Mir A Hossain; Suming Huang; Kazuhiko Igarashi; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2018-09-14       Impact factor: 4.272

8.  Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences.

Authors:  Richard A Morgan; Feiyang Ma; Mildred J Unti; Devin Brown; Paul George Ayoub; Curtis Tam; Lindsay Lathrop; Bamidele Aleshe; Ryo Kurita; Yukio Nakamura; Shantha Senadheera; Ryan L Wong; Roger P Hollis; Matteo Pellegrini; Donald B Kohn
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-18       Impact factor: 5.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.